Description

Triglimisave-2 Tablet is a medicine that contains a combination of Glimepiride and Pioglitazone as its active ingredients. Glimepiride is a sulfonylurea anti-diabetic medication that helps lower blood sugar levels in individuals suffering from type 2 diabetes. It stimulates the pancreas to release insulin, allowing the body to utilize glucose effectively. Pioglitazone, on the other hand, is a thiazolidinedione that enhances the body’s sensitivity to insulin, thereby improving blood sugar control. Triglimisave-2 Tablet is primarily used as an adjunct to diet and exercise to treat type 2 diabetes in adults. It helps to maintain stable blood sugar levels and reduces the risk of complications associated with diabetes. These tablets are not recommended for the treatment of type 1 diabetes or diabetic ketoacidosis. Regular monitoring of blood sugar levels is also recommended.

Additional information